rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Biomea Fusion, Inc.

BMEA · Nasdaq

Health CareBiotechnologyNot moving yet

BMEA stood above a rising 150-day average in 5 of the last 52 weekly readings, and has been out of that trend for the last 4 weeks. It is 48.5% below that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−14 points in four weeks); Health Care: 28% (−9 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 4
Industry in uptrend
18% -14 in 4 wk
Insider buys, 12 months
$196K
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
59 (+0)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 5 of 52 weeks.

21 Apr – 20 Oct
18%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$147KNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months4
Sale orders, 12 months0
Buyers · sellers2 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders59+0 on the quarter
New · exited12 · 11
Reported value$36.5M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
FMR LLCadded · filed 13 Aug 20268,814,946$13.0M+1,5870.0%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20262,829,927$4.2M+232,627+9.0%
MARSHALL WACE, LLPadded · filed 13 Aug 20262,049,802$3.0M+851,251+71.0%
Aisling Capital Management LPunchanged · filed 13 Aug 20262,048,757$3.0M00.0%
RENAISSANCE TECHNOLOGIES LLCadded · filed 13 Aug 20261,455,474$2.1M+142,676+10.9%
FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A.added · filed 23 Jul 2026723,176$1.1M+166,140+29.8%
BlackRock, Inc.added · filed 7 Aug 2026715,445$1.1M+74,010+11.5%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026708,854$1.0M+160,668+29.3%
SUSQUEHANNA INTERNATIONAL GROUP, LLPreduced · filed 14 Aug 2026612,735$901K-17,130−2.7%
Mariner, LLCreduced · filed 13 Aug 2026594,726$874K-59,852−9.1%
31 Mar 2023 – 30 Jun 2026
597897Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Elizabeth Faust Company insiderDirector · last 10 Jun 20260 · 0
Eric Aguiar Company insiderDirector · last 10 Jun 20260 · 0
Julianne Averill Company insiderDirector · last 10 Jun 20260 · 0
Sumita Ray Company insiderDirector · last 10 Jun 20260 · 0
Michael J.M. Hitchcock Company insiderInterim CEO · last 1 Apr 20263 · 0
Rainer M. Erdtmann Company insiderDirector, Officer · last 1 Apr 20268 · 0
Bihua Chen Company insiderDirector, 10% owner · last 11 Jun 20250 · 0
Franco Valle Company insiderChief Financial Officer · last 30 Nov 20243 · 0
Cormorant Global Healthcare Master Fund, Lp Company insider10% owner · last 12 Jun 20241 · 0
Juan Pablo Frias Company insiderChief Medical Officer · last 31 May 20240 · 0
Thomas Andrew Butler Company insiderChief Executive Officer · last 17 Jan 20244 · 0
A2a Pharmaceuticals, Inc. Company insider10% owner · last 1 Jun 20232 · 10

Same industry

MRNA ModernaLeading+167%
ENTX Entera BioLeading+52%
XNCR XencorLeading+41%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Dec 2025-176%
Interest coverFY 2025 · to 31 Dec 2025-44.95×
Share count trendFY 2025 · to 20 Mar 20260.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$55.8M

Analyst forecasts

No analyst forecasts yet.